Preferred Label : Albinism, oculocutaneous, type II;
Symbol : OCA2;
CISMeF acronym : BOCA; OCA2;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Oculocutaneous albinism, type II; Oculocutaneous albinism, tyrosinase-positive; Albinism II;
Included titles and symbols : Albinism, brown oculocutaneous; Brown oculocutaneous albinism; BOCA;
Description : Tyrosinase-positive oculocutaneous albinism (OCA, type II) is an autosomal recessive
disorder in which the biosynthesis of melanin pigment is reduced in skin, hair, and
eyes. Although affected infants may appear at birth to have OCA type I, or complete
absence of melanin pigment, most patients with OCA type II acquire small amounts of
pigment with age. Individuals with OCA type II have the characteristic visual anomalies
associated with albinism, including decreased acuity and nystagmus, which are usually
less severe than in OCA type I (Lee et al., 1994; King et al., 2001). OCA type II
has a highly variable phenotype. The hair of affected individuals may turn darker
with age, and pigmented nevi or freckles may be seen. African and African American
individuals may have yellow hair and blue-gray or hazel irides. One phenotypic variant,
'brown OCA,' has been described in African and African American populations and is
characterized by light brown hair and skin color and gray to tan irides. The hair
and irides may turn darker with time and the skin may tan with sun exposure; the ocular
features of albinism are present in all variants (King et al., 2001). In addition,
previous reports of so-called 'autosomal recessive ocular albinism,' (see, e.g., Witkop
et al., 1978 and O'Donnell et al., 1978) with little or no obvious skin involvement,
are now considered most likely to be part of the phenotypic spectrum of OCA1 or OCA2
(Lee et al., 1994; King et al., 2001).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the homolog of the mouse pink-eyed dilution gene (OCA2, 611409.0001);
Laboratory abnormalities : Hair bulbs will pigment when incubated with tyrosine;
Prefixed ID : #203200;
Origin ID : 203200;
UMLS CUI : C0268495;
Automatic exact mappings (from CISMeF team)
Broader ORDO disease(s)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)